CA2457996C - Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same - Google Patents

Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same Download PDF

Info

Publication number
CA2457996C
CA2457996C CA002457996A CA2457996A CA2457996C CA 2457996 C CA2457996 C CA 2457996C CA 002457996 A CA002457996 A CA 002457996A CA 2457996 A CA2457996 A CA 2457996A CA 2457996 C CA2457996 C CA 2457996C
Authority
CA
Canada
Prior art keywords
preparation
weight
schenk
water
wight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002457996A
Other languages
English (en)
French (fr)
Other versions
CA2457996A1 (en
Inventor
Pengfei Tu
Zhihong Song
Li Lei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinphar Pharmaceutical Co Ltd
Original Assignee
Sinphar Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinphar Pharmaceutical Co Ltd filed Critical Sinphar Pharmaceutical Co Ltd
Publication of CA2457996A1 publication Critical patent/CA2457996A1/en
Application granted granted Critical
Publication of CA2457996C publication Critical patent/CA2457996C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
    • G01N27/04—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance
    • G01N27/12—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance of a solid body in dependence upon absorption of a fluid; of a solid body in dependence upon reaction with a fluid, for detecting components in the fluid
    • G01N27/125—Composition of the body, e.g. the composition of its sensitive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01M—TESTING STATIC OR DYNAMIC BALANCE OF MACHINES OR STRUCTURES; TESTING OF STRUCTURES OR APPARATUS, NOT OTHERWISE PROVIDED FOR
    • G01M3/00—Investigating fluid-tightness of structures
    • G01M3/02—Investigating fluid-tightness of structures by using fluid or vacuum
    • G01M3/04—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point
    • G01M3/16—Investigating fluid-tightness of structures by using fluid or vacuum by detecting the presence of fluid at the leakage point using electric detection means
    • G—PHYSICS
    • G08—SIGNALLING
    • G08B—SIGNALLING SYSTEMS, e.g. PERSONAL CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
    • G08B21/00—Alarms responsive to a single specified undesired or abnormal condition and not otherwise provided for
    • G08B21/02—Alarms for ensuring the safety of persons
    • G08B21/12—Alarms for ensuring the safety of persons responsive to undesired emission of substances, e.g. pollution alarms
    • G08B21/16—Combustible gas alarms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Electrochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Toxicology (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Combustion & Propulsion (AREA)
  • Hematology (AREA)
CA002457996A 2003-02-18 2004-02-17 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same Expired - Lifetime CA2457996C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW92103351 2003-02-18
TW092103351A TW200416036A (en) 2003-02-18 2003-02-18 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same

Publications (2)

Publication Number Publication Date
CA2457996A1 CA2457996A1 (en) 2004-08-18
CA2457996C true CA2457996C (en) 2009-08-04

Family

ID=32847870

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002457996A Expired - Lifetime CA2457996C (en) 2003-02-18 2004-02-17 Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same

Country Status (6)

Country Link
US (2) US7087252B2 (2)
JP (2) JP4926376B2 (2)
KR (1) KR20040074614A (2)
AU (1) AU2004200624B2 (2)
CA (1) CA2457996C (2)
TW (1) TW200416036A (2)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736167B1 (en) * 2005-06-20 2018-03-21 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Extracts obtained from cell line cultures from Syringa vulgaris IRB-SV25/B (DMS:16857), their preparation and use
JP4965132B2 (ja) * 2006-01-27 2012-07-04 森下仁丹株式会社 更年期障害改善剤
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
CN100475189C (zh) * 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
JPWO2008093678A1 (ja) * 2007-01-29 2010-05-20 オリザ油化株式会社 ヒアルロニダーゼ阻害剤
US20080261896A1 (en) * 2007-04-11 2008-10-23 Sinphar Pharmaceutical Co., Ltd. Testosterone generating and metabolizing enhancer
JP2008280271A (ja) * 2007-05-09 2008-11-20 Oriza Yuka Kk 皮膚光老化予防剤
JP2009196895A (ja) * 2008-02-19 2009-09-03 Oriza Yuka Kk チロシナーゼ阻害剤
JP2009196908A (ja) * 2008-02-20 2009-09-03 Yomeishu Seizo Co Ltd リパーゼ阻害剤及び飲食品
JP2009263279A (ja) * 2008-04-25 2009-11-12 Oriza Yuka Kk エラスターゼ阻害剤
TWI486162B (zh) * 2010-06-16 2015-06-01 Sinphar Pharmaceutical Co Ltd 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途
CN102329346A (zh) * 2011-05-31 2012-01-25 苏州派腾生物医药科技有限公司 一种从肉苁蓉中提取松果菊苷的方法
CN102304156B (zh) * 2011-06-24 2016-03-16 浙江爱诺药业股份有限公司 一种苯乙醇苷类成份及其制备方法和用途
CA2859227C (en) * 2011-12-16 2019-01-22 Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou) Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions
CN102670436B (zh) * 2012-03-13 2013-09-25 珈侬生化科技(中国)有限公司 含管花肉苁蓉提取物的美白抗衰老化妆品及其制备方法
JP6151003B2 (ja) * 2012-10-26 2017-06-21 学校法人近畿大学 カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品
US9339522B2 (en) * 2013-05-30 2016-05-17 Sinphar Pharmaceutical Co., Ltd. Method for regulating blood glucose level
WO2015154721A1 (zh) * 2014-04-10 2015-10-15 杏辉天力（杭州）药业有限公司 异类叶升麻苷衍生物及其制造方法与用途
MY190399A (en) 2014-05-08 2022-04-21 Access Business Group Int Llc A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject
CN105111255A (zh) * 2015-08-12 2015-12-02 青海伊纳维康生物科技有限公司 一种肉苁蓉中松果菊苷和毛蕊花糖苷的提取分离方法
MY194024A (en) * 2016-01-12 2022-11-08 Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou Use of cistanche tubulosa extract and isoacteoside in protection of muscles
CN108057038B (zh) * 2018-02-24 2020-09-01 上海中医药大学附属曙光医院 一种治疗肝纤维化的组合物及其应用
CN109369739A (zh) * 2018-11-16 2019-02-22 山东省药学科学院 一种具有脑保护活性的过山蕨植物提取物及其制备方法
CN110812375A (zh) * 2019-12-12 2020-02-21 中国海洋大学 一种老鼠簕中苯乙醇苷类提取物及其制备方法与作为抗肝损伤药物的应用
CN112608404B (zh) * 2020-12-01 2023-01-10 石河子大学 一种氨基功能化异质结构多孔微球及其制备方法和应用
CN112586515A (zh) * 2020-12-22 2021-04-02 长江绿银(无锡)科技有限公司 一种北美车前中提取化感物质和苯乙醇苷类化合物的方法
CN115778971B (zh) * 2023-01-08 2025-06-24 中国中医科学院中药研究所 一种包含肉苁蓉成分的药物组合物及其用途
CN116549466A (zh) * 2023-06-06 2023-08-08 上海泰楚生物技术有限公司 一种毛蕊花糖苷化合物在制备抗动脉血栓形成的药物中的应用
CN121242107B (zh) * 2025-12-04 2026-04-21 内蒙古自治区农牧业科学院 肉苁蓉茯茶饮品及其制备方法和货架期预测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07223964A (ja) * 1994-02-01 1995-08-22 Du Pont Merck Pharmaceut Co ホスホリパーゼａ２阻害剤
JPH0940597A (ja) * 1994-12-13 1997-02-10 Natl Sci Council シナモフィリン及びその誘導体とこれらの製造方法及び血小板凝集抑制薬剤、気管弛緩薬剤、酸化防止剤及び血管弛緩薬剤

Also Published As

Publication number Publication date
JP2012021022A (ja) 2012-02-02
AU2004200624B2 (en) 2006-02-16
TW200416036A (en) 2004-09-01
TWI331529B (2) 2010-10-11
AU2004200624A1 (en) 2004-09-02
JP2004250449A (ja) 2004-09-09
US20040162246A1 (en) 2004-08-19
US7087252B2 (en) 2006-08-08
JP4926376B2 (ja) 2012-05-09
KR20040074614A (ko) 2004-08-25
JP5352655B2 (ja) 2013-11-27
CA2457996A1 (en) 2004-08-18
US20060233896A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
CA2457996C (en) Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same
CN101484179B (zh) 用于治疗和预防炎性疾病的络石藤提取物组合物
CN101554409A (zh) 荜茇生物碱及其制备方法、制剂和用途
WO2008145064A1 (en) The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
CN108558837B (zh) 黄烷醇生物碱及其制备方法和应用
CN108610387B (zh) 一种具有神经细胞保护活性的四个异黄烷苷类化合物及其制备方法
CN101380379B (zh) 千里香叶总黄酮及其制备方法及用途
WO2004039759A1 (fr) Compose naturel servant dans le traitement de diabetes, sa preparation et son utilisation
EP1498131B1 (en) Medicinal preparation containing phenylethanoid glycosides extracted from Cistanche tubulosa
CN107929544B (zh) 白及属植物中militarine部位及单体的制备方法及其应用
CN101119740B (zh) 中药地榆及其提取物在制备升高红细胞和血红蛋白药物中的应用
CN103156997A (zh) 一种治疗慢性肝病的中药有效部位组合物及其制备方法和应用
CN109091602B (zh) 韭菜子有效成分、提取方法及其在制备保护肝损伤药物方面的应用
WO2006063515A1 (fr) Utilisation de radix sanguisorbae et de son extrait pour la preparation d’un medicament visant a accroitre la numeration erythrocytaire et le taux d’hemoglobine
CN104224952A (zh) 一种各种成分比例稳定均一的大黄总蒽醌的制备方法
CN101322734B (zh) 具有抗炎免疫作用的轮叶党参总皂苷及其制备方法
CN111166735B (zh) 邻苯二甲酸-双-(2-乙基庚基)酯在抑制脂肪蓄积中的应用
CN103520451B (zh) 一种具有降血脂作用的分蘖葱头组合物
CN101249129B (zh) 一种治疗糖尿病的中药提取物组合物及其医药用途
CN112717031A (zh) 一种用于治疗阿尔茨海默症的药物组合物及其制备方法
CN103193788B (zh) 一个具有神经保护作用的石蒜碱类化合物
CN116621800B (zh) 黄花蒿醇a-c及其药物组合物和其制备方法与应用
CN103788058B (zh) 一种木脂素类化合物及其在防治阿尔茨海默症中的应用
CN101979021B (zh) 一组具有抗氧化活性的复方提取物
CN111568935B (zh) 赤苍藤提取物在制备抗肿瘤药物中的应用

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20240219